SEARCH

SEARCH BY CITATION

References

  • Baruchel, A., Cayuela, J.M. & Landman, J. (1999) Prospective assessment of the prognostic value of TEL-AML1 expression in childhood acute lymphoblastic leukemia (ALL). Blood, 94, 502a.
  • Borkhardt, A., Cazzaniga, G., Viehmann, S., Valsecchi, M.G., Ludwig, W.D., Burci, L., Mangioni, S., Schrappe, M. & Riehm, H. (1997) Incidence and clinical relevance of TEL-AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Blood, 90, 571577.
  • Brisco, M.J., Condon, J., Hughes, E., Nech, S.H., Sykes, P.H., Seshadri, R., Toogood, I., Water, K., Tauro, G. & Eckhert, H. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196200.
  • Chessells, J.M., Richards, S.M., Bailey, C.C., Lilleyman, J.S. & Eden, O.B. (1995a) Sex and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. British Journal of Haematology, 89, 372380.
  • Chessells, J.M., Bailey, C.C. & Richards, S.M. (1995b) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Lancet, 345, 143148.
  • Chessells, J.M., Swansbury, G.J., Reeves, B., Bailey, C.C. & Richards, S.M. (1997) Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. British Journal of Haematology, 99, 93100.
  • Chessells, J.M., Hall, E., Prentice, H.G., Durrant, J., Bailey, C.C. & Richards, S.M. (1998) The impact of age on outcome in lymphoblastic leukaemia: MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukaemia, 12, 463473.
  • Coustan-Smith, E., Behm, F., Sanchez, , Boyett, J.M., Hancock, M.L., Raimondi, S.C., Rubnitz, J.E., Ribera, G.K., Sandlund, J.T., Pui, C.H. & Campoma, D. (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia. Lancet, 351, 550554.DOI: 10.1016/s0140-6736(97)10295-1
  • Crist, W., Shuster, J., Look, T., Borowitz, M., Behm, F., Bowman, P., Frankel, L., Pullen, J., Krance, R. & Steuber, P. (1992) Current results of studies of immunophenotype-age and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Leukemia, 6, 162166.
  • Donadieu, J., Auclerc, M.F., Baruchel, A., Leblanc, T., Landman-Powker, J., Perel, Y., Michel, G., Gornu, G. & Bordigoni, P. (1998) Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. British Journal of Haematology, 102, 729739.DOI: 10.1046/j.1365-2141.1998.00818.x
  • Dordelmann, M., Schrappe, M., Reiter, A., Zimmerman, M., Graf, N., Schott, G., Lampert, F., Harbbott, J., Niemeyer, M. & Ludwig, W.D. (1998) Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Munster Group. Leukemia, 12, 645651.DOI: 10.1038/sj.leu.2400989
  • Forestier, E., Gustafsson, G., Von Heideman, A., Heim, S., Hernnell, O., Mitelman, F., Nordenson, I. & Swolin, B. (1997) Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986–91. Acta Paediatrics, 86, 819825.
  • Gaynon, P.S., Steinherz, P.J., Bleyer, W.A., Ablin, A.R., Albo, V.C., Finkelstein, J.Z., Grossman, N.J., Novak, L.J. & Pyesmany, A.F. (1993) Improved therapy for children with acute lymphoblastic leukemia and unfavourable presenting features: a follow up report of the Children's Cancer Study Group CCG-106. Journal of Clinical Oncology, 11, 22342242.
  • Gaynon, P.S., Desai, A.A., Bostrom, B.C., Hutchinson, P.J., Lange, B.J., Nachman, J.B., Reaman, G.H., Sathar, N.H., Steinherz, P.J., Trigg, M.E., Tubergen, D.G. & Uckun, F.M. (1997) Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer, 80, 17171726.DOI: 10.1002/(sici)1097-0142(19971101)80:9<1717::aid-cncr4>3.0.co;2-b
  • Gustaffson, G., Kreuger, A., Clausen, N., Garwicz, S., Kristinsson, J., Lies, O., Moe, P.H., Perkkio, M., Yssing, M. & Saarinen-Pihkala, U.M. (1998) Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Acta Paediatrics, 87, 11511161.DOI: 10.1080/080352598750031149
  • Hann, I., Vora, A., Richards, S., Hill, F., Gibson, B., Lilleyman, J.S., Kinsley, S., Mitchell, C. & Eden, O.B. (2000) Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC AL97 randomized trials. Leukemia, 14, 356363.DOI: 10.1038/sj.leu.2401704
  • Hann, I.M., Richards, S.M., Eden, O.B. & Hill, F.G. (1998) Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Leukemia, 12, 12491255.DOI: 10.1038/sj.leu.2401093
  • Harbott, J., Viehmann, S., Borkhardt, A., Henze, G. & Lampert, F. (1997) Incidence of TEL/AML1 fusion gene analysed consecutively in children with acute lymphoblastic leukemia in relapse. Blood, 90, 49334937.
  • Heerema, N.A., Sather, H., Sensel, M.G., Lui-Marcs, W., Lange, B.J., Bostrom, B.C., Nachman, J.B., Steinherz, P.G. & Hutchinson, R. (1999) Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood, 94, 15371544.
  • Henze, G., Fengler, R., Reiter, A., Ritter, J. & Riehm, H. (1990) Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia. Hamatological Bluttransfusion, 33, 483488.
  • Hutchinson, R., Neerhout, R. & Bertolone, S. (1996) Should therapy be intensified for patients with good risk ALL? Blood, 88, 668a.
  • Lilleyman, J.S., Hann, I.M., Stevens, R.F., Richards, S.M., Eden, O.B., Chessells, J.M. & Bailey, C.C. (1992) Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. British Journal of Haematology, 81, 5257.
  • Lilleyman, J.S., Gibson, B.E., Stevens, R.F., Will, A.M., Hann, I.M., Richards, S.M. & Hill, F.G. (1997) Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. British Journal of Haematology, 97, 603606.DOI: 10.1046/j.1365-2141.1997.1002914.x
  • Loh, M.L., Silverman, L.B., Young, M.L., Neuberg, D., Grolub, T.R., Sallan, S.E. & Gilliland, D.G. (1998) Incidence of TEL/AML1 infusion in children with relapsed acute lymphoblastic leukemia. Blood, 92, 47924797.
  • Miller, D.R., Coccia, P.F., Bleyer, W.A., Lukens, J.N., Siegel, S.E., Sather, H.N. & Hammond, G.D. (1989) Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Children's Cancer Study Group. Journal of Clinical Oncology, 7, 18071815.
  • Nachman, J.B., Sather, H.N., Sensel, M.G., Trigg, M.E., Breslow, N.E., Lukens, J.N., Wolff, L., Uckun, F.M. & Gaynon, P.S. (1998) Augmented post-induction therapy for children with high risk acute lymphoblastic leukemia and a slow response to initial therapy. New England Journal of Medicine, 338, 16631671.DOI: 10.1056/NEJM199806043382304
  • Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. & Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patients. II. Analysis and examples. The British Journal of Cancer, 35, 139.
  • Pui, C.H., Carroll, A.J., Head, D.R., Riamondi, S.C., Shuster, J.J., Crist, W.M., Link, M.P., Borowit, Z.M. & Behm, F.G. (1990) Near-Triploid and Near-Tetraploid acute lymphoblastic leukaemia of childhood. Blood, 76, 590596.
  • Pui, C.H., Boyett, J.M., Relling, M.V., Harrison, P.L., Rivera, G.K., Behm, F.G., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Grajjar, A. & Evans, W.E. (1999) Sex differences in prognosis for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 17, 818824.
  • Raimondi, S.C., Roberson, P.K., Pui, C.H., Behm, F. & Rivera, G.K. (1992) Hyperdiploid (47–50) acute lymphoblastic leukaemia in children. Blood, 79, 32453252.
  • Riehm, H., Reiter, A., Schrappe, M., Berthol, F., Dopfer, R., Gerein, V., Ludwig, R., Ritter, J., Stollman, B. & Henze, G. (1987) Corticosteroid-dependent reduction of leucocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83). Klinische Pediaatrics, 199, 151160.
  • Rubnitz, J.E., Downing, J.R., Pui, C.H., Shurtleffs, A., Raimondi, S.C., Evans, W.E., Head, D.R., Crist, W.M. & Rivera, G.K. (1997) TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. Journal of Clinical Oncology, 15, 11501157.
  • Sandlund, J.T., Downing, J.R. & Crist, W. (1996) Non-Hodgkin's Lymphoma in Childhood. New England Journal of Medicine, 334, 12381247.DOI: 10.1056/NEJM199605093341906
  • SAS Institute Inc. (1990) SAS Procedures Guide, Version 6 (3rd edn). SAS Institute Inc., Cary, NC.
  • Seeger, K., Adams, H.P., Buchwald, D., Beyermann, B., Bremens, B., Niemeyer, C., Ritter, J., Schwabe, D., Harms, D., Schrappe, M. & Henze, G. (1998) TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Munster Study Group. Blood, 91, 17161722.
  • Smith, M., Arthur, D.C., Camitta, B., Carroll, A.J., Crist, W., Graynon, P., Gelber, R., Heerema, N., Korn, E.L. & Link, M. (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 14, 1824.
  • Steinherz, P.G., Gaynon, P.S., Breneman, J.C., Cherlow, J.M., Grossman, N.J., Kersssey, J.H., Johnstone, H.S., Sather, H.N. & Trigs, M.E. (1996) Cytoreduction and prognosis in acute lymphoblastic leukemia – the importance of early marrow response: report from the Children's Cancer Group. Journal of Clinical Oncology, 14, 389398.
  • Tubergen, D.G., Gilchrist, G.S., O'Brien, R.T., Coccia, P.F., Sather, H.N., Waskerwitz, M.J. & Hammond, G.D. (1993) Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. Journal of Clinical Oncology, 11, 527537.
  • Uckun, F.M., Nachman, J.B., Sather, H., Sensel, M.G., Kraft, P., Steinherz, P.G., Lange, B., Hutchinson, R., Reaman, G.H., Gaynon, P.S. & Heerema, N.A. (1998a) Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer, 83, 20302039.DOI: 10.1002/(sici)1097-0142(19981101)83:9<2030::aid-cncr21>3.3.co;2-h
  • Uckun, F.M., Sensel, M.G., Sather, H.N., Gaynon, P.S., Arthur, D.C., Lange, B.J., Steinherz, P.G. & Kraft, P. (1998b) Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. Journal of Clinical Oncology, 16, 527535.
  • Uckun, F.M., Nachman, J.B., Ssather, H., Sensel, M.G., Kraft, P., Steinherz, P.G., Lange, B., Hutchinson, R., Reaman, G.H., Gaynon, P.S. & Heerema, N.A. (1999) Poor treatment outcome of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. Leukemia and Lymphoma, 33, 101106.
  • Van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Coral, L., Stolz, F., Schrappe, M., Masera, G., Kauups, W.A. & Gadner, H. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, 352, 17311738.DOI: 10.1016/s0140-6736(98)04058-6
  • Viana, M.B., Murao, M., Ramos, G., Oliveira, H.M., De Carvalho, R.I., De Bastos, M., Colosimo, E.A. & Silverstrini, W.S. (1994) Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Archives of Diseases of Childhood, 71, 304310.